2026 Q3 Portfolio Activity
In 2026 Q3, SPHERA FUNDS MANAGEMENT LTD. maintained a portfolio of 136 distinct positions. The most significant new addition was TEVA PHARMACEUTICAL INDS LTD, now representing 4.60% of the total fund value. They heavily accumulated shares in ALNYLAM PHARMACEUTICALS INC, increasing the position by 1016.7%. Conversely, SPHERA FUNDS MANAGEMENT LTD. completely exited their position in TEVA PHARMACEUTICAL INDS LTD.
Position History
hover any row below to update
Loading…
Total Positions
136
Quarter
2026 Q3
Top Holding
MLYS (4.7%)
Top 10 Concentration
33.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 136
SPHERA FUNDS MANAGEMENT LTD. Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MLYS
MINERALYS THERA...
|
Healthcare | 4.70% | 5.17% |
#1
1
Prev: #2
|
4.4 |
—
|
-148,110 | -10.1% |
P
S
|
1,321,861 | $33,218,367 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TEVJF
TEVA PHARMACEUT...
|
Healthcare | 4.60% | — |
#2
Prev: #—
|
6.8 |
—
|
821,282 | — |
NEW
|
821,282 | $32,522,767 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 4.21% | 0.42% |
#3
74
Prev: #77
|
5.7 |
—
|
109,802 | 1016.7% |
P
S
|
120,602 | $29,757,337 | 2015 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.37% | 2.44% |
#4
6
Prev: #10
|
4.8 |
—
|
141,910 | 64.5% |
P
S
|
361,897 | $23,852,631 | 2013 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SOXX
ISHARES TR
|
ETF | 2.97% | — |
#5
Prev: #—
|
5.2 |
—
|
37,000 | — |
NEW
|
37,000 | $21,039,680 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 2.90% | 2.38% |
#6
5
Prev: #11
|
3.7 |
—
|
66,371 | 27.1% |
P
S
|
311,717 | $20,510,979 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TSEM
TOWER SEMICONDU...
|
Technology | 2.72% | 3.68% |
#7
4
Prev: #3
|
1.1 |
—
|
-23,525 | -21.7% |
P
S
|
84,740 | $19,272,418 | 2016 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 2.68% | 2.89% |
#8
3
Prev: #5
|
1.6 |
—
|
-7,328 | -0.7% |
P
S
|
1,007,278 | $18,936,826 | 2016 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 2.49% | 2.45% |
#9
Prev: #9
|
1.5 |
—
|
-35,304 | -10.7% |
P
S
|
293,246 | $17,594,760 | 2014 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 2.42% | 2.72% |
#10
3
Prev: #7
|
1.0 |
—
|
-20,863 | -21.6% |
P
S
|
75,763 | $17,113,346 | 2013 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.27% | 2.32% |
#11
1
Prev: #12
|
2.9 |
—
|
42,200 | 9.2% |
P
S
|
501,540 | $16,059,311 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVMI
NOVA LTD
|
Technology | 2.13% | 1.78% |
#12
1
Prev: #13
|
3.9 |
—
|
13,875 | 55.1% |
P
S
|
39,044 | $15,039,749 | 2014 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 1.84% | 1.22% |
#13
7
Prev: #20
|
3.2 |
—
|
8,376 | 48.1% |
P
S
|
25,795 | $12,999,648 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 1.67% | 3.10% |
#14
10
Prev: #4
|
0.7 |
—
|
-75,000 | -50.0% |
P
S
|
75,000 | $11,825,999 | 2017 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
META
META PLATFORMS ...
|
Communication Services | 1.66% | — |
#15
Prev: #—
|
4.2 |
—
|
16,200 | — |
NEW
|
16,200 | $11,747,916 | 2016 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 1.62% | 0.95% |
#16
21
Prev: #37
|
3.6 |
—
|
584,675 | 81.2% |
P
S
|
1,304,732 | $11,455,547 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SNY
SANOFI SA
|
Healthcare | 1.57% | 1.50% |
#17
Prev: #17
|
1.6 |
—
|
no change | no change |
P
S
|
269,515 | $11,112,103 | 2014 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AZNCF
ASTRAZENECA PLC
|
Unknown | 1.56% | 1.55% |
#18
2
Prev: #16
|
2.6 |
—
|
6,000 | 9.6% |
P
S
|
68,530 | $11,065,539 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARKG
PUT
ARK ETF TR
|
PUT Option | 1.53% | — |
#19
Prev: #—
|
4.1 |
—
|
200,000 | — |
NEW
|
200,000 | $10,844,000 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 1.41% | 1.63% |
#20
5
Prev: #15
|
1.1 |
—
|
-51,276 | -12.3% |
P
S
|
366,288 | $9,955,708 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 1.31% | 1.26% |
#21
2
Prev: #19
|
1.5 |
—
|
no change | no change |
P
S
|
8,040 | $9,302,923 | 2014 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KLAC
KLA CORP
|
Technology | 1.25% | — |
#22
Prev: #—
|
4.0 |
—
|
45,220 | — |
NEW
|
45,220 | $8,814,735 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LRCX
LAM RESEARCH CO...
|
Technology | 1.20% | 1.04% |
#23
4
Prev: #27
|
3.0 |
—
|
7,430 | 40.2% |
P
S
|
25,900 | $8,508,409 | 2017 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PFE
PFIZER INC
|
Healthcare | 1.15% | 0.90% |
#24
15
Prev: #39
|
1.5 |
—
|
no change | no change |
P
S
|
286,000 | $8,156,720 | 2013 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 1.15% | 0.95% |
#25
11
Prev: #36
|
2.5 |
—
|
15,000 | 7.6% |
P
S
|
211,408 | $8,122,295 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.08% | 1.16% |
#26
2
Prev: #24
|
1.4 |
—
|
no change | no change |
P
S
|
80,400 | $7,655,286 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 1.08% | 0.96% |
#27
8
Prev: #35
|
1.4 |
—
|
no change | no change |
P
S
|
28,831 | $7,632,719 | 2013 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.07% | 1.04% |
#28
1
Prev: #29
|
2.4 |
—
|
50,000 | 19.7% |
P
S
|
304,250 | $7,591,038 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.06% | 0.61% |
#29
28
Prev: #57
|
3.4 |
—
|
51,200 | 80.6% |
P
S
|
114,738 | $7,510,749 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 1.03% | 1.00% |
#30
2
Prev: #32
|
0.9 |
—
|
-33,000 | -7.9% |
P
S
|
383,417 | $7,315,596 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AMAT
APPLIED MATLS I...
|
Technology | 1.03% | 1.04% |
#31
3
Prev: #28
|
2.9 |
—
|
3,260 | 29.5% |
P
S
|
14,300 | $7,312,734 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 1.03% | — |
#32
Prev: #—
|
3.9 |
—
|
73,716 | — |
NEW
|
73,716 | $7,299,358 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.03% | — |
#33
Prev: #—
|
3.9 |
—
|
229,700 | — |
NEW
|
229,700 | $7,286,084 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CAMT
CAMTEK LTD
|
Technology | 1.03% | — |
#34
Prev: #—
|
3.9 |
—
|
46,800 | — |
NEW
|
46,800 | $7,265,700 | 2017 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 1.00% | 0.98% |
#35
1
Prev: #34
|
0.9 |
—
|
-10,000 | -17.1% |
P
S
|
48,600 | $7,062,066 | 2013 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVCT
NUVECTIS PHARMA...
|
Healthcare | 0.97% | 0.92% |
#36
2
Prev: #38
|
0.9 |
—
|
-59,520 | -15.5% |
P
S
|
323,425 | $6,830,736 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVS
NOVARTIS AG
|
Healthcare | 0.91% | 1.02% |
#37
7
Prev: #30
|
0.9 |
—
|
-5,000 | -10.0% |
P
S
|
45,000 | $6,412,843 | 2013 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABBV
ABBVIE INC
|
Healthcare | 0.82% | 0.99% |
#38
5
Prev: #33
|
0.3 |
—
|
-8,000 | -26.4% |
P
S
|
22,256 | $5,821,947 | 2014 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TRAX
FIRST TRACKS BI...
|
Healthcare | 0.80% | 0.07% |
#39
61
Prev: #100
|
3.3 |
—
|
132,361 | 474.8% |
P
S
|
160,237 | $5,678,799 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.78% | 1.21% |
#40
19
Prev: #21
|
0.3 |
—
|
-113,700 | -22.8% |
P
S
|
385,329 | $5,517,911 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MSLE
SATELLOS BIOSCI...
|
Healthcare | 0.77% | 0.66% |
#41
10
Prev: #51
|
0.8 |
—
|
-13,900 | -2.1% |
P
S
|
638,690 | $5,428,865 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 0.73% | — |
#42
Prev: #—
|
3.8 |
—
|
1,222,687 | — |
NEW
|
1,222,687 | $5,171,966 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.72% | 2.56% |
#43
35
Prev: #8
|
0.3 |
—
|
-249,851 | -42.5% |
P
S
|
338,643 | $5,089,804 | 2015 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.68% | 0.82% |
#44
2
Prev: #42
|
0.8 |
—
|
-67,000 | -13.9% |
P
S
|
416,747 | $4,780,088 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYBN
CYBIN INC
|
Unknown | 0.67% | 1.40% |
#45
27
Prev: #18
|
0.3 |
—
|
-1,232,602 | -76.1% |
P
S
|
388,151 | $4,770,376 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.67% | 1.06% |
#46
20
Prev: #26
|
0.3 |
—
|
-403,600 | -53.6% |
P
S
|
349,383 | $4,706,189 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 0.65% | 0.55% |
#47
17
Prev: #64
|
1.3 |
—
|
no change | no change |
P
S
|
22,400 | $4,597,824 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVO
NOVO-NORDISK A ...
|
Healthcare | 0.65% | 0.75% |
#48
4
Prev: #44
|
1.3 |
—
|
no change | no change |
P
S
|
120,677 | $4,574,865 | 2019 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.65% | 0.75% |
#49
4
Prev: #45
|
0.8 |
—
|
-13,000 | -11.5% |
P
S
|
99,765 | $4,573,228 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 0.62% | 0.23% |
#50
40
Prev: #90
|
3.2 |
—
|
2,195,496 | 1826.5% |
P
S
|
2,315,696 | $4,376,665 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 136 holdings